50180 Federal Register / Vol. 70, No. 165 / Friday, August 26, 2005 / Rules and Regulations 

TABLE 2.—AFFECTED REAR COMPRESSOR FRONT HUBS—Continued 

SN P/N Description 

9V8107 ................................................................................................... 726230 HUB—REAR COMPRESSOR, FRONT. 

The P/N and description for each SN are provided as reference information. 

Prohibition Against Installation of Disks and 

Hubs Listed in Table 1 

(g) After the effective date of this AD, do 

not install any disk or hub listed in Table 1 

of this AD that has zero cycles-in-service 

since May 14, 2001. 

(h) After the effective date of this AD, do 

not return to service any engine that has a 

disk or hub listed in Table 1 of this AD that 

has zero cycles-in-service since May 14, 

2001. 

Definition of Shop Visit 

(i) A shop visit is defined as an engine and/ 

or module removal where engine 

maintenance entails separation of pairs of 

major engine flanges or the removal of a disk, 

hub or spool at a maintenance facility, 

regardless of the scheduled maintenance 

action or the reason for engine removal. 

Definition of Part Accessibility 

(j) For the purposes of this AD, 

accessibility of the HPC rear hub is removing 

the hub from the engine. 

Alternative Methods of Compliance 

(k) The Manager, Engine Certification 

Office, has the authority to approve 

alternative methods of compliance for this 

AD if requested using the procedures found 

in 14 CFR 39.19. 

Related Information 

(l) None. 

Material Incorporated by Reference 

(m) You must use Pratt & Whitney Alert 

Service Bulletin (ASB) No. JT8D A6442, 

dated April 4, 2003, to perform the actions 

required by this AD. The Director of the 

Federal Register approved the incorporation 

by reference of this service bulletin in 

accordance with 5 U.S.C. 552(a) and 1 CFR 

part 51. Contact Pratt & Whitney, 400 Main 

St., East Hartford, CT 06108; telephone (860) 

565–7700; fax (860) 565–1605, for a copy of 

this service information. You may review 

copies at the Docket Management Facility; 

U.S. Department of Transportation, 400 

Seventh Street, SW., Nassif Building, Room 

PL–401, Washington, DC 20590–0001, on the 

Internet at http://dms.dot.gov, or at the 

National Archives and Records 

Administration (NARA). For information on 

the availability of this material at NARA, call 

202–741–6030, or go to: http:// 

www.archives.gov/federal_register/ 

code_of_federal_regulations/ 

ibr_locations.html. 

Issued in Burlington, Massachusetts, on 

August 19, 2005. 

Richard Noll, 

Acting Manager, Engine and Propeller 

Directorate, Aircraft Certification Service. 

[FR Doc. 05–16903 Filed 8–25–05; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF COMMERCE 

National Institute of Standards and 

Technology 

15 CFR Part 280 

[Docket No: 050705177–5177–01] 

RIN 0693–AB55 

Fastener Quality Act 

AGENCY: National Institute of Standards 

and Technology, United States 

Department of Commerce. 

ACTION: Final rule. 

SUMMARY: The Director of the National 

Institute of Standards and Technology 

(NIST), United States Department of 

Commerce, and the Director of the 

United States Patent and Trademark 

Office (USPTO), United States 

Department of Commerce, are amending 

the rules that implement the Fastener 

Quality Act of 1999 to provide that all 

documents submitted in connection 

with the recordal of fastener insignia 

must be mailed to a particular postal 

box maintained by United States Patent 

and Trademark Office. 

DATES: This final rule is effective on 

September 26, 2005. 

FOR FURTHER INFORMATION CONTACT: Ari 

Leifman, Office of the Commissioner for 

Trademarks, P.O. Box 1451, Alexandria, 

Virginia 22313–1451, telephone number 

(571) 272–9572. 

SUPPLEMENTARY INFORMATION: 

Background 

The Fastener Quality Act of 1999, 

Public Law 101–592 (as amended by 

Pub. L. 104–113, Pub. L. 105–234 and 

Pub. L. 106–34) requires the Secretary of 

Commerce to establish a program for the 

recordation of the identifying insignia of 

certain fasteners. The rules set forth at 

Subpart D of 15 CFR 280.300 et seq. 

accordingly provide for a recordation 

system, and that system is maintained at 

the United States Patent and Trademark 

Office (USPTO). One of the rules, 15 

CFR 280.310(d), provides that all 

documents pertaining to recordation 

must be mailed to a particular postal 

box maintained by the USPTO in 

Washington, DC. 

The efficiency of the insignia 

recordation program will be enhanced if 

documents submitted in connection 

with the program are mailed to a postal 

box that is close to the USPTO’s 

headquarters in Alexandria, Virginia. 

Accordingly, Section 280.310(d) is 

amended to provide that these 

documents be mailed to that postal box. 

This final rule amends section 280.30, 

Application for Insignia, to identify the 

postal box to which all documents 

pertaining to recordation should be sent. 

Additional Information 

Executive Order 12866 

This rule of agency organization and 

management is not subject to Executive 

Order 12866. 

Executive Order 12612 

This rule does not contain policies 

with Federalism implications sufficient 

to warrant preparation of a Federalism 

assessment under Executive Order 

12612. 

Administrative Procedure Act 

Prior notice and an opportunity for 

public comment are not required for this 

rule of agency organization, procedure, 

or practice. 5 U.S.C. 553(b)(A). This rule 

revises the regulations to identify the 

address where documents submitted in 

connection with the recordal of fastener 

insignia may be mailed. 

Regulatory Flexibility Act 

Because notice and comment are not 

required under 5 U.S.C. 553, or any 

other law, the analytical requirements of 

the Regulatory Flexibility Act (5 U.S.C. 

601 et seq.) are inapplicable. As such, a 

regulatory flexibility analysis is not 

required. 

Paperwork Reduction Act 

This rule involves a collection of 

information that is subject to the 

Paperwork Reduction Act (PRA), and 

that has been approved by the Office of 

Management and Budget (OMB) under 

control number 0651–0028. 

Notwithstanding any other provision of 

the law, no person is required to 

comply, nor shall any person be subject 

to penalty for failure to comply with, a 

collection of information, subject to the 

requirements of the Paperwork 

Reduction Act, unless that collection of 

information displays a currently valid 

OMB Control Number. 

Federal Register / Vol. 70, No. 165 / Friday, August 26, 2005 / Rules and Regulations 50181 

National Environmental Policy Act 

This rule will not significantly affect 

the quality of the human environment. 

Therefore, an environmental assessment 

or Environmental Impact Statement is 

not required to be prepared under the 

National Environmental Policy Act of 

1969. 

List of Subjects in 15 CFR Part 280, 

Subpart D 

Application for Insignia. 

■ For the reasons set forth in the 

preamble, the National Institute of 

Standards and Technology and the 

United States Patent and Trademark 

Office amend 15 CFR Part 280, Subpart 

D, as follows: 

PART 280—[AMENDED] 

■ 1. The authority citation for Part 280 

continues to read: 

Authority: 15 U.S.C. 5401 et seq. 

■ 2. Section 280.310 is amended by 

revising paragraph (d) to read as 

follows: 

§ 280.310 Application for insignia. 

* * * * * 

(d) Applications and other documents 

should be addressed to: Director, United 

States Patent and Trademark Office, 

P.O. Box 16471, Arlington, VA 22215– 

1471 Attn: FQA 

Dated: August 10, 2005. 

Jon W. Dudas, 

Under Secretary of Commerce for Intellectual 

Property and Director of the United States 

Patent and Trademark Office. 

William Jeffrey, 

Director, National Institute of Standards and 

Technology. 

[FR Doc. 05–17020 Filed 8–25–05; 8:45 am] 

BILLING CODE 3510–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Parts 510, 520, 522, 524, and 

529 

Animal Drugs, Feeds, and Related 

Products; Withdrawal of Approval of 

New Animal Drug Applications 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule; technical 

amendment. 

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations by removing 

those portions that reflect approval of 16 

new animal drug applications (NADAs) 

and 1 abbreviated NADA (ANADA) 

because they are no longer 

manufactured or marketed. In a notice 

published elsewhere in this issue of the 

Federal Register, FDA is withdrawing 

approval of these NADAs. 

DATES: This rule is effective September 

6, 2005. 

FOR FURTHER INFORMATION CONTACT: 

Pamela K. Esposito, Center for 

Veterinary Medicine (HFV–212), Food 

and Drug Administration, 7519 Standish 

Pl., Rockville, MD 20855, 301–827– 

7818, e-mail: pesposit@cvm.fda.gov. 

SUPPLEMENTARY INFORMATION: The 

following sponsors have requested that 

FDA withdraw approval of the 16 

NADAs and 1 ANADA listed in table 1 

of this document because the products 

are no longer manufactured or 

marketed: 

TABLE 1. 

Sponsor NADA Number, Product (Drug) 21 CFR Section Affected (Sponsor Drug Labeler Code) 

Abbott Laboratories, North Chicago, IL 60064 NADA 99–568, FURANACE Caps 

(nifurpirinol) 

529.1526 (000074) 

Biocraft Laboratories, Inc., 92 Route 46, Elmwood Park, NJ 07407 NADA 140–889, DERM–OTIC Ointment (neomycin sulfate; nystatin; thiostrepton; 

triamcinolone acetonide) 

524.1600a (000332) 

First Priority, Inc., 1585 Todd Farm Dr., 

Elgin, IL 60123 

NADA 48–646, THERAZONE Injection 

(phenylbutazone) 

522.1720 (058829) 

Happy Jack, Inc., Snow Hill, NC 28580 NADA 121–556, Selenium Sulfide Suspension 

(selenium disulfide) 

524.2101 (023851) 

NADA 121–723, Nitrofurazone Dressing 524.1580b (023851) 

NADA 125–137, FILARICIDE Capsules 

(diethylcarbamazine citrate) 

520.622d (023851) 

IMPAX Laboratories, Inc., 30831 Huntwood 

Ave., Hayward, CA 94544 

NADA 92–151, N-Butyl Chloride Canine 

Worming Caps 

520.260 (000115) 

NADA 65–065, Tetracycline HCl Caps 520.2345a (000115) 

NADA 138–900, Dichlorophene/Toluene 520.580 (000115) 

Jorgensen Laboratories, Inc., 1450 North 

Van Buren Ave., Loveland, CO 80538 

NADA 10–481, SUREJETS (salicylic acid) 529.2090 (048087) 

Pliva d.d., Ulica grada Vukovara 49, 10000 

Zagreb, Croatia 

ANADA 200–232, GEOMYCIN 200 Injection 

(oxytetracycline) 

522.1660a (011722) 

Purina Mills, Inc., P.O. Box 66812, St. Louis, 

MO 63166–6812 

NADA 65–113 AUREO Sulfa Soluble Powder 

(chlortetracycline/sulfamethazine) 

N/A (017800) 

Roche Vitamins, Inc., 45 Waterview Blvd., 

Parsippany, NJ 07054–1298 

NADA 140–848, VETEEZE Injection 

(diazepam) 

522.575 (063238) 

Teva Pharmaceuticals USA, 650 Cathill Rd., 

Sellersville, PA 18960 

NADA 131–806, Furosemide Tablets 520.1010 (000093)